
Talmizen AMH 40mg/5mg/12.5mg Tablet
Marketer
Indizen Pharmaceutical
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Talmizen AMH 40mg/5mg/12.5mg Tablet
Amlodipine/Hydrochlorothiazide/Valsartan 40mg/5mg/12.5mg tablets are prescribed for hypertension management when monotherapy proves insufficient. This triple-combination medication effectively lowers elevated blood pressure, mitigating the risk of future cardiovascular events such as stroke and heart attack. These tablets may be taken with or without food; dosage is individualized and should be consistent, ideally at the same time daily. Continuous use, as directed by your physician, is crucial; discontinuation increases stroke and heart attack risk. The formulation includes a diuretic, promoting increased urination, therefore avoid ingestion within four hours of bedtime. Regular use, even during asymptomatic periods, maximizes therapeutic benefit, as hypertension is often silent. Common side effects may include headache, fatigue, dizziness, altered taste perception, flu-like symptoms, diarrhea, and sinus congestion. Report persistent, worsening, or bothersome side effects to your doctor promptly. Adequate hydration is recommended to counteract potential side effects like thirst, dry mouth, and muscle weakness. Prior to initiating treatment, disclose any pre-existing liver or kidney conditions, pregnancy, breastfeeding status, and a complete list of current medications, especially those for cardiovascular or hypertensive conditions. Regular monitoring of blood pressure, kidney function, electrolyte balance, and blood glucose levels is essential to assess treatment efficacy and safety.
Uses of Talmizen AMH 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Talmizen AMH 40mg/5mg/12.5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Talmizen AMH 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or fracturing it. While it can be taken with or without food, consistent daily timing is recommended.
Common Side effects of Talmizen AMH 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Talmizen AMH 40mg/5mg/12.5mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Talmizen AMH 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
How Talmizen AMH 40mg/5mg/12.5mg Tablet works:
Each Talmizen AMH 40mg/5mg/12.5mg tablet unites Telmisartan, Amlodipine, and Hydrochlorothiazide. Telmisartan, an angiotensin II receptor antagonist, and Amlodipine, a calcium channel blocker, collaboratively dilate blood vessels, reducing blood pressure. Hydrochlorothiazide, a diuretic, facilitates fluid and electrolyte excretion via urination, contributing to vasodilation and enhanced circulation in the long term.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Talmizen AMH 40mg/5mg/12.5mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Use of Talmizen AMH 40mg/5mg/12.5mg tablets is contraindicated during pregnancy due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Talmizen AMH 40mg/5mg/12.5mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Talmizen AMH 40mg/5mg/12.5mg Tablets. These potential side effects include dizziness, headaches, nausea, and fatigue, all of which can compromise concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Talmizen AMH 40mg/5mg/12.5mg tablets, as dosage modification may be necessary. Physician consultation is advised. Talmizen AMH 40mg/5mg/12.5mg tablets are not recommended for individuals with severely compromised kidney function.
LiverCAUTION
Patients with liver impairment should exercise caution when using Talmizen AMH 40mg/5mg/12.5mg tablets. Dosage modification of Talmizen AMH 40mg/5mg/12.5mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Talmizen AMH 40mg/5mg/12.5mg Tablet :
Should you forget a Talmizen AMH 40mg/5mg/12.5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Talmizen AMH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
